Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Return on Invested Capital (2016 - 2020)

Historic Return on Invested Capital for Sanofi (SNY) over the last 5 years, with Q2 2020 value amounting to 0.4%.

  • Sanofi's Return on Invested Capital rose 2500.0% to 0.4% in Q2 2020 from the same period last year, while for Jun 2020 it was 0.4%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.09% for FY2024, which is 0.0% changed from last year.
  • As of Q2 2020, Sanofi's Return on Invested Capital stood at 0.4%, which was up 2500.0% from 0.33% recorded in Q1 2020.
  • In the past 5 years, Sanofi's Return on Invested Capital registered a high of 540.42% during Q3 2016, and its lowest value of 0.1% during Q1 2018.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.26% (2016), whereas its average is 38.81%.
  • Per our database at Business Quant, Sanofi's Return on Invested Capital crashed by -5401600bps in 2017 and then skyrocketed by 2500bps in 2020.
  • Over the past 5 years, Sanofi's Return on Invested Capital (Quarter) stood at 0.27% in 2016, then fell by -27bps to 0.19% in 2017, then dropped by -26bps to 0.14% in 2018, then skyrocketed by 92bps to 0.28% in 2019, then surged by 46bps to 0.4% in 2020.
  • Its Return on Invested Capital stands at 0.4% for Q2 2020, versus 0.33% for Q1 2020 and 0.28% for Q4 2019.